安科生物(300009.SZ)发布前三季度业绩，归母净利润5.51亿元，下降6.48%

Core Viewpoint - Anke Bio's revenue for the first three quarters of 2025 reached 1.963 billion yuan, reflecting a year-on-year growth of 2.15% while the net profit attributable to shareholders decreased by 6.48% to 551 million yuan [1] Financial Performance - The company's operating revenue for the first three quarters was 1.963 billion yuan, showing a year-on-year increase of 2.15% [1] - The net profit attributable to shareholders was 551 million yuan, which represents a year-on-year decrease of 6.48% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 519 million yuan, down 6.56% year-on-year [1] - Basic earnings per share stood at 0.3297 yuan [1]